A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry

PLoS Pathogens

Volumn 13, Issue 5, 2017, Pages

  Aydin, Inci ^a,b   Villalonga Planells, Ruth ^a,b   Greune, Lilo ^a,b   Bronnimann, Matthew P ^c   Calton, Christine M ^d   Becker, Miriam ^a,b   Lai, Kun Yi ^a,b   Campos, Samuel K ^c,d,e   Schmidt, M Alexander ^a,b   Schelhaas, Mario ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Cells in Motion   (Germany)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e The University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CYCLOPHILIN B; LIPOCORTIN 2; NOCODAZOLE; CHROMATIN; L2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS DNA;

ARTICLE; CELL NUCLEUS MEMBRANE; CHROMOSOME TRANSLOCATION; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; DENSITOMETRY; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; METAPHASE CHROMOSOME; PAPILLOMAVIRIDAE; PHYLOGENETIC TREE; PLASMID; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROMETAPHASE; PROTEIN EXPRESSION; SANGER SEQUENCING; SITE DIRECTED MUTAGENESIS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL NUCLEUS; CHROMATIN; CHROMOSOME; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; INTRACELLULAR MEMBRANE; METABOLISM; MITOSIS; MUTATION; PHYSIOLOGY; REPORTER GENE; TRANSPORT AT THE CELLULAR LEVEL; VIRION; VIROLOGY;

BIOLOGICAL TRANSPORT; CAPSID PROTEINS; CELL NUCLEUS; CHROMATIN; CHROMOSOMES; DNA, VIRAL; GENES, REPORTER; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTRACELLULAR MEMBRANES; MITOSIS; MUTATION; ONCOGENE PROTEINS, VIRAL; VIRION;

EID: 85020164319     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006308     Document Type: Article

References (78)

1. Chouhy D, Bolatti EM, Perez GR, Giri AA, Analysis of the genetic diversity and phylogenetic relationships of putative human papillomavirus types. The Journal of general virology. 2013;94(Pt 11):2480–8. doi: 10.1099/vir.0.055137-0 23997181
2. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907. doi: 10.1016/S0140-6736(07)61416-0 17826171
3. zur Hausen H, Papillomaviruses and cancer: from basic studies to clinical application. Nature reviews Cancer. 2002;2(5):342–50. doi: 10.1038/nrc798 12044010
4. Cohen S, Au S, Pante N, How viruses access the nucleus. Biochim Biophys Acta. 2011;1813(9):1634–45. doi: 10.1016/j.bbamcr.2010.12.009 21167871
5. Aydin I, Weber S, Snijder B, Samperio Ventayol P, Kuhbacher A, Becker M, et al. Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS pathogens. 2014;10(5):e1004162. PubMed Central PMCID: PMC4038628. doi: 10.1371/journal.ppat.1004162 24874089
6. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF, Establishment of human papillomavirus infection requires cell cycle progression. PLoS pathogens. 2009;5(2):e1000318. Epub 2009/02/28. PubMed Central PMCID: PMC2642596. doi: 10.1371/journal.ppat.1000318 19247434
7. Egawa K, Do human papillomaviruses target epidermal stem cells?Dermatology. 2003;207(3):251–4. doi: 73085 14571065
8. Schmitt A, Rochat A, Zeltner R, Borenstein L, Barrandon Y, Wettstein FO, et al. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. Journal of virology. 1996;70(3):1912–22. PubMed Central PMCID: PMCPMC190020. 8627717
9. Modis Y, Trus BL, Harrison SC, Atomic model of the papillomavirus capsid. The EMBO journal. 2002;21(18):4754–62. Epub 2002/09/18. PubMed Central PMCID: PMC126290. doi: 10.1093/emboj/cdf494 12234916
10. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, Schiller JT, et al. Arrangement of L2 within the Papillomavirus capsid. Journal of virology. 2008;82(11):5190–7. doi: 10.1128/JVI.02726-07 18367526
11. Howley PM, Papillomavirinae: the viruses and their replication. In: Virology (2nd edition), Lippincott-Raven Publishers, Philadelphia, Pa. Fields Virology. 1996;2nd ed., 1996:2045–76.
12. Meyers C, Frattini MG, Hudson JB, Laimins LA, Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science. 1992;257(5072):971–3. Epub 1992/08/14. 1323879
13. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT, Maturation of papillomavirus capsids. Journal of virology. 2005;79(5):2839–46. Epub 2005/02/15. doi: 10.1128/JVI.79.5.2839-2846.2005 15709003
14. Bienkowska-Haba M, Patel HD, Sapp M, Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS pathogens. 2009;5(7):e1000524. Epub 2009/07/25. PubMed Central PMCID: PMC2709439. doi: 10.1371/journal.ppat.1000524 19629175
15. Cerqueira C, Liu Y, Kuhling L, Chai W, Hafezi W, van Kuppevelt TH, et al. Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cellular microbiology. 2013;15(11):1818–36. Epub 2013/04/23. doi: 10.1111/cmi.12150 23601855
16. Cerqueira C, Samperio Ventayol P, Vogeley C, Schelhaas M, Kallikrein-8 proteolytically processes Human papillomaviruses in the extracellular space to facilitate entry into host cells. Journal of virology. 2015.
17. Culp TD, Budgeon LR, Christensen ND, Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology. 2006;347(1):147–59. doi: 10.1016/j.virol.2005.11.025 16376962
18. Guan J, Bywaters SM, Brendle SA, Ashley RE, Makhov AM, Conway JF, et al. Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site. Structure. 2016.
19. Richards RM, Lowy DR, Schiller JT, Day PM, Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(5):1522–7. doi: 10.1073/pnas.0508815103 16432208
20. Selinka HC, Florin L, Patel HD, Freitag K, Schmidtke M, Makarov VA, et al. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. Journal of virology. 2007;81(20):10970–80. doi: 10.1128/JVI.00998-07 17686860
21. Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, et al. The evolving field of human papillomavirus receptor research: a review of binding and entry. Journal of virology. 2013;87(11):6062–72. Epub 2013/03/29. PubMed Central PMCID: PMC3648114. doi: 10.1128/JVI.00330-13 23536685
22. Schelhaas M, Shah B, Holzer M, Blattmann P, Kuhling L, Day PM, et al. Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS pathogens. 2012;8(4):e1002657. Epub 2012/04/27. PubMed Central PMCID: PMC3334892. doi: 10.1371/journal.ppat.1002657 22536154
23. Spoden G, Kuhling L, Cordes N, Frenzel B, Sapp M, Boller K, et al. Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. Journal of virology. 2013;87(13):7765–73. Epub 2013/04/26. PubMed Central PMCID: PMC3700296. doi: 10.1128/JVI.00370-13 23616662
24. Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT, Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. Journal of virology. 2013;87(7):3862–70. Epub 2013/01/25. PubMed Central PMCID: PMC3624235. doi: 10.1128/JVI.03222-12 23345514
25. Bienkowska-Haba M, Williams C, Kim SM, Garcea RL, Sapp M, Cyclophilins Facilitate Dissociation of the HPV16 Capsid Protein L1 from the L2/DNA Complex Following Virus Entry. Journal of virology. 2012. Epub 2012/07/05.
26. DiGiuseppe S, Bienkowska-Haba M, Hilbig L, Sapp M, The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network. Virology. 2014;458–459:93–105. PubMed Central PMCID: PMCPMC4115330.
27. Day PM, Roden RB, Lowy DR, Schiller JT, The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. Journal of virology. 1998;72(1):142–50. Epub 1998/01/07. PubMed Central PMCID: PMC109358. 9420209
28. Becker KA, Florin L, Sapp C, Sapp M, Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology. 2003;314(1):161–7. 14517069
29. Wang JW, Roden RB, L2, the minor capsid protein of papillomavirus. Virology. 2013;445(1–2):175–86. PubMed Central PMCID: PMCPMC3770800. doi: 10.1016/j.virol.2013.04.017 23689062
30. Darshan MS, Lucchi J, Harding E, Moroianu J, The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. Journal of virology. 2004;78(22):12179–88. Epub 2004/10/28. PubMed Central PMCID: PMC525100. doi: 10.1128/JVI.78.22.12179-12188.2004 15507604
31. Mamoor S, Onder Z, Karanam B, Kwak K, Bordeaux J, Crosby L, et al. The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic. Virology. 2012;422(2):413–24. Epub 2011/12/14. PubMed Central PMCID: PMC3249505. doi: 10.1016/j.virol.2011.11.007 22154072
32. Finnen RL, Erickson KD, Chen XS, Garcea RL, Interactions between papillomavirus L1 and L2 capsid proteins. Journal of virology. 2003;77(8):4818–26. Epub 2003/03/29. PubMed Central PMCID: PMC152166. doi: 10.1128/JVI.77.8.4818-4826.2003 12663788
33. Klucevsek K, Daley J, Darshan MS, Bordeaux J, Moroianu J, Nuclear import strategies of high-risk HPV18 L2 minor capsid protein. Virology. 2006;352(1):200–8. doi: 10.1016/j.virol.2006.04.007 16733063
34. Okun MM, Day PM, Greenstone HL, Booy FP, Lowy DR, Schiller JT, et al. L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. Journal of virology. 2001;75(9):4332–42. Epub 2001/04/05. PubMed Central PMCID: PMC114178. doi: 10.1128/JVI.75.9.4332-4342.2001 11287582
35. Roden RB, Day PM, Bronzo BK, Yutzy WHt, Yang Y, Lowy DR, et al. Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection. Journal of virology. 2001;75(21):10493–7. doi: 10.1128/JVI.75.21.10493-10497.2001 11581419
36. Bergant M, Banks L, SNX17 facilitates infection with diverse papillomavirus types. Journal of virology. 2013;87(2):1270–3. Epub 2012/11/02. PubMed Central PMCID: PMC3554065. doi: 10.1128/JVI.01991-12 23115288
37. Pim D, Broniarczyk J, Bergant M, Playford MP, Banks L, A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking. Journal of virology. 2015;89(20):10145–55. PubMed Central PMCID: PMCPMC4580170. doi: 10.1128/JVI.01499-15 26202251
38. Popa A, Zhang W, Harrison MS, Goodner K, Kazakov T, Goodwin EC, et al. Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection. PLoS pathogens. 2015;11(2):e1004699. PubMed Central PMCID: PMCPMC4334968. doi: 10.1371/journal.ppat.1004699 25693203
39. Bronnimann MP, Chapman JA, Park CK, Campos SK, A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection. Journal of virology. 2013;87(1):464–73. Epub 2012/10/26. PubMed Central PMCID: PMC3536380. doi: 10.1128/JVI.01539-12 23097431
40. Kamper N, Day PM, Nowak T, Selinka HC, Florin L, Bolscher J, et al. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. Journal of virology. 2006;80(2):759–68. Epub 2005/12/28. PubMed Central PMCID: PMC1346844. doi: 10.1128/JVI.80.2.759-768.2006 16378978
41. DiGiuseppe S, Keiffer TR, Bienkowska-Haba M, Luszczek W, Guion LG, Muller M, et al. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry. Journal of virology. 2015;89(20):10442–52. PubMed Central PMCID: PMCPMC4580179. doi: 10.1128/JVI.01588-15 26246568
42. DiGiuseppe S, Luszczek W, Keiffer TR, Bienkowska-Haba M, Guion LG, Sapp MJ, Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(22):6289–94. doi: 10.1073/pnas.1600638113 27190090
43. Florin L, Becker KA, Lambert C, Nowak T, Sapp C, Strand D, et al. Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. Journal of virology. 2006;80(13):6691–6. Epub 2006/06/16. PubMed Central PMCID: PMC1488977. doi: 10.1128/JVI.00057-06 16775357
44. Schneider MA, Spoden GA, Florin L, Lambert C, Identification of the dynein light chains required for human papillomavirus infection. Cellular microbiology. 2011;13(1):32–46. Epub 2010/12/21. doi: 10.1111/j.1462-5822.2010.01515.x 21166973
45. Bund T, Spoden GA, Koynov K, Hellmann N, Boukhallouk F, Arnold P, et al. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16. Cellular microbiology. 2014;16(8):1179–200. doi: 10.1111/cmi.12271 24444361
46. Day PM, Baker CC, Lowy DR, Schiller JT, Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(39):14252–7. Epub 2004/09/24. PubMed Central PMCID: PMC521143. doi: 10.1073/pnas.0404229101 15383670
47. Calton CM, Bronnimann MP, Manson AR, Li S, Chapman JA, Suarez-Berumen M, et al. Translocation of the Papillomavirus L2/vDNA Complex Across the Limiting Membrane Requires the Onset of Mitosis. PLoS pathogens. 13(5): e1006200.
48. Harper JV, Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol Biol. 2005;296:157–66. 15576930
49. Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, et al. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PloS one. 2012;7(8):e43519. Epub 2012/08/29. PubMed Central PMCID: PMC3425544. doi: 10.1371/journal.pone.0043519 22927980
50. Bergant Marusic M, Ozbun MA, Campos SK, Myers MP, Banks L, Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic. 2012;13(3):455–67. Epub 2011/12/14. PubMed Central PMCID: PMC3276720. doi: 10.1111/j.1600-0854.2011.01320.x 22151726
51. Lipovsky A, Popa A, Pimienta G, Wyler M, Bhan A, Kuruvilla L, et al. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(18):7452–7. Epub 2013/04/10. PubMed Central PMCID: PMC3645514. doi: 10.1073/pnas.1302164110 23569269
52. Bossis I, Roden RB, Gambhira R, Yang R, Tagaya M, Howley PM, et al. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. Journal of virology. 2005;79(11):6723–31. PubMed Central PMCID: PMCPMC1112158. doi: 10.1128/JVI.79.11.6723-6731.2005 15890910
53. Laniosz V, Nguyen KC, Meneses PI, Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18. Journal of virology. 2007;81(14):7435–48. PubMed Central PMCID: PMCPMC1933340. doi: 10.1128/JVI.00571-07 17475643
54. Yang R, Yutzy WHt, Viscidi RP, Roden RB, Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. The Journal of biological chemistry. 2003;278(14):12546–53. Epub 2003/02/01. doi: 10.1074/jbc.M208691200 12560332
55. Beckett D, Kovaleva E, Schatz PJ, A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein science: a publication of the Protein Society. 1999;8(4):921–9. PubMed Central PMCID: PMCPMC2144313.
56. Aydin I, Schelhaas M, Viral Genome Tethering to Host Cell Chromatin: Cause and Consequences. Traffic. 2016;17(4):327–40. doi: 10.1111/tra.12378 26787361
57. Bordeaux J, Forte S, Harding E, Darshan MS, Klucevsek K, Moroianu J, The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. Journal of virology. 2006;80(16):8259–62. Epub 2006/07/29. PubMed Central PMCID: PMC1563822. doi: 10.1128/JVI.00776-06 16873281
58. Fay A, Yutzy WHt, Roden RB, Moroianu J, The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding. Journal of virology. 2004;78(24):13447–54. PubMed Central PMCID: PMCPMC533947. doi: 10.1128/JVI.78.24.13447-13454.2004 15564455
59. Mallon RG, Wojciechowicz D, Defendi V, DNA-binding activity of papillomavirus proteins. Journal of virology. 1987;61(5):1655–60. PubMed Central PMCID: PMCPMC254149. 3033292
60. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB, Protein disorder prediction: implications for structural proteomics. Structure. 2003;11(11):1453–9. 14604535
61. Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, Luger K, et al. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science. 2006;311(5762):856–61. doi: 10.1126/science.1120541 16469929
62. Matsumura S, Persson LM, Wong L, Wilson AC, The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains. Journal of virology. 2010;84(5):2318–30. PubMed Central PMCID: PMCPMC2820923. doi: 10.1128/JVI.01097-09 20032179
63. Barbera AJ, Ballestas ME, Kaye KM, The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistence. Journal of virology. 2004;78(1):294–301. PubMed Central PMCID: PMCPMC303411. doi: 10.1128/JVI.78.1.294-301.2004 14671111
64. McBride AA, Replication and partitioning of papillomavirus genomes. Adv Virus Res. 2008;72:155–205. PubMed Central PMCID: PMCPMC3151303. doi: 10.1016/S0065-3527(08)00404-1 19081491
65. You J, Croyle JL, Nishimura A, Ozato K, Howley PM, Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell. 2004;117(3):349–60. 15109495
66. Poddar A, Reed SC, McPhillips MG, Spindler JE, McBride AA, The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes. Journal of virology. 2009;83(2):640–50. PubMed Central PMCID: PMCPMC2612381. doi: 10.1128/JVI.01936-08 19004936
67. Florin L, Schafer F, Sotlar K, Streeck RE, Sapp M, Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology. 2002;295(1):97–107. Epub 2002/05/30. doi: 10.1006/viro.2002.1360 12033769
68. Steigemann P, Wurzenberger C, Schmitz MH, Held M, Guizetti J, Maar S, et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell. 2009;136(3):473–84. Epub 2009/02/11. doi: 10.1016/j.cell.2008.12.020 19203582
69. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE, Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. The Journal of cell biology. 1988;106(3):761–71. Epub 1988/03/01. PubMed Central PMCID: PMC2115116. 2450098
70. Buck CB, Thompson CD, Roberts JN, Muller M, Lowy DR, Schiller JT, Carrageenan is a potent inhibitor of papillomavirus infection. PLoS pathogens. 2006;2(7):e69. Epub 2006/07/15. PubMed Central PMCID: PMC1500806. doi: 10.1371/journal.ppat.0020069 16839203
71. Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, et al. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology. 2004;321(2):205–16. Epub 2004/03/31. doi: 10.1016/j.virol.2003.12.027 15051381
72. Buck CB, Pastrana DV, Lowy DR, Schiller JT, Efficient intracellular assembly of papillomaviral vectors. Journal of virology. 2004;78(2):751–7. doi: 10.1128/JVI.78.2.751-757.2004 14694107
73. Buck CB, Pastrana DV, Lowy DR, Schiller JT, Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods in molecular medicine. 2005;119:445–62. doi: 10.1385/1-59259-982-6:445 16350417
74. Ishii Y, Tanaka K, Kondo K, Takeuchi T, Mori S, Kanda T, Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody. Virology. 2010;406(2):181–8. Epub 2010/08/06. doi: 10.1016/j.virol.2010.07.019 20684966
75. Rubio I, Seitz H, Canali E, Sehr P, Bolchi A, Tommasino M, et al. The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies. Virology. 2011;409(2):348–59. Epub 2010/11/16. doi: 10.1016/j.virol.2010.10.017 21074234
76. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O, New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59(3):307–21. doi: 10.1093/sysbio/syq010 20525638
77. Chevenet F, Brun C, Banuls AL, Jacq B, Christen R, TreeDyn: towards dynamic graphics and annotations for analyses of trees. BMC Bioinformatics. 2006;7:439. PubMed Central PMCID: PMCPMC1615880. doi: 10.1186/1471-2105-7-439 17032440
78. Simossis VA, Heringa J, PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res. 2005;33(Web Server issue):W289–94. PubMed Central PMCID: PMCPMC1160151. doi: 10.1093/nar/gki390 15980472